Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033 is a research paper published in Neuro-Oncology (2020). On theSindex it has a DataRank of 0.606. It has been cited 56 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.606
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Cancer Research UK
Grant: 6850
European Organization for Research and Treatment of Cancer Research Fund
UK National Institutes of Health Research
Australian National Health and Medical Research Council
National Institute for Health Research (NIHR)
Merck & Co
Swiss Cancer League
US National Cancer Institute
FWCI
2.46
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Exploring the prognostic potential of m6A methylation regulators in low-grade glioma: implications for tumor microenvironment modulation
Additional file 1 of Exploring the prognostic potential of m6A methylation regulators in low-grade glioma: implications for tumor microenvironment modulation
Additional file 3 of Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients
Additional file 2 of Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients
Additional file 4 of Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients
Additional file 3 of Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients
Additional file 2 of Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients
Additional file 4 of Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients
Additional file 1 of Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients
Additional file 1 of Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients